Next generation crispr/CAS9-rnai mouse models for accelerated drug discovery research
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA188154
- Recipient
-
Mirimus, Inc. UEI CP76MKEFKFE4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,408,150
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Brooklyn, NY 11226, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $751,587 | |
| Original award | $656,563 |
Quick answers
Who received award R44CA188154?
R44CA188154 was awarded to Mirimus, Inc. by National Cancer Institute (National Institutes of Health) on August 4, 2014.
How much is award R44CA188154 worth?
$1,408,150 has been obligated on R44CA188154.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award